Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Mindpeak logo — Our mission is to enable personalised cancer treatment throu...

Mindpeak

Our mission is to enable personalised cancer treatment through AI tissue diagnostics

Founded 2018 Germany Hamburg, Germany 53 employees Series A Total: $19.67M AI, Biotechnology +2

General Information

Company Name Mindpeak
Founded Year 2018
Location Germany Hamburg, Germany
Employees 53
Industries AI, Biotechnology, Health Care +1
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Offices as of Oct 2026
Hamburg, Germany
Social

BounceWatch is an independent company data service, not affiliated with Mindpeak. To contact Mindpeak, visit mindpeak.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Mindpeak compare?

A PDF of Mindpeak and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Mindpeak soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Oct 15, 2026

Mindpeak announced a partnership with Biobase to co-host a pre-conference beach party in San Diego on October 16, 2026, before PathVisions26.

Event Participation Oct 12, 2026

Mindpeak is participating in the WorldADC 2026 event in San Diego, presenting a poster (#29) on Tuesday, October 13.

Board Appointment Oct 09, 2026

Mindpeak has announced the hiring of Ehab ElGabry, MD as their new Chief Advisor, Biopharma & Companion Diagnostics Strategy, bringing over 25 years of experience from companies like Roche and Cell…

Actively Hiring Sep 24, 2026

Hiring for 2 positions in the last 30 days.

Get alerts when Mindpeak shows new signals

AI Insight

Bounce Watch AI
2 weeks ago

Mindpeak is exhibiting strong post-Series A momentum, marked by the achievement of crucial IVDR certification which unlocks market access in Europe. This regulatory milestone is complemented by a new commercial co-selling partnership with Revolune, significantly expanding their reach in spatial biology. Furthermore, the company continues to innovate its core AI pathology platform, rolling out advanced capabilities to decode complex biological signals and optimize pre-analytics for molecular testing. These strategic moves underscore a focused drive towards market penetration, regulatory leadership, and deep product innovation in precision diagnostics.

Signal Types
Regulatory Milestone Partnership Product Development
Strategic Labels
Market Expansion Product Innovation Regulatory Compliance
Next Move: Commercialization
·
Impact: 8/10
·
Ideal For: Digital Pathology VCs — Growth Stage

About Mindpeak

Mindpeak is based in Hamburg, Germany, and specializes in AI tissue diagnostics, focusing on enabling personalized cancer treatment. The company partners with pathology and university labs to assist cancer experts through automation tools powered by artificial intelligence.

Founded in 2018, Mindpeak offers services such as AI technology for biomarker discovery, clinical trial support, and diagnostic imaging solutions. It caters to biopharmaceutical companies, diagnostic laboratories, and clinical researchers. Mindpeak operates on a B2B, SaaS, and platform business model, deriving revenue through subscription, usage-based, and service fee models.

Business keywords: AI tissue diagnostics, personalised cancer treatment, medical image analysis, automation tools, visual diagnosis, deep learning, cancer diagnostics, pathology labs, biomarker quantification, cell quantification, reproducible diagnoses, cancer specialist support, workload reduction for specialists, university lab partnerships

Services & Products

AI technology for biomarker discovery
Clinical trial support
Diagnostic imaging solutions
Automated macrodissection
Pathology frontier model development

Target Customers

Biopharmaceutical companies Diagnostic laboratories Clinical researchers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $15.30M 16
Apex Ventures Motu Ventures Nina Ventures
Apex Ventures, Motu Ventures +14
01 Oct 2024
Early VC Undisclosed 7
Apex Ventures Motu Ventures Nina Ventures
Apex Ventures, Motu Ventures +5
01 Feb 2024
Grant €1.37M 1
European Innovation Council
European Innovation Council
01 Mar 2020
Seed $3.00M 5
Apex Ventures Motu Ventures Nina Ventures
Apex Ventures, Motu Ventures +3
01 Oct 2019

Latest News

View All
Mindpeak and Revolune Announce Commercial Co-Selling Partnership to Deliver End-to-End Spatial Biolo... — EIN Presswire
Mindpeak and Revolune Announce Commercial Co-Selling Partnership to Deliver End-to-End Spatial Biology Solutions
EIN Presswire Sep 21, 2026
PhenoScout AI: Mindpeak Unveils Next-Generation Multiplex Immunofluorescence Analysis — Fox2now.com
PhenoScout AI: Mindpeak Unveils Next-Generation Multiplex Immunofluorescence Analysis
Fox2now.com Sep 29, 2025
Mindpeak to deploy and evaluate AI-Powered Digital Pathology Risk Assessment Tools for Breast Cancer... — Biospace.com
Mindpeak to deploy and evaluate AI-Powered Digital Pathology Risk Assessment Tools for Breast Cancer in collaboration with AstraZeneca
Biospace.com Mar 19, 2025
Mindpeak and Sagis Diagnostics to launch Collaborative Study on AI-Enhanced Detection of Nail Mycosi... — Businesswire.com
Mindpeak and Sagis Diagnostics to launch Collaborative Study on AI-Enhanced Detection of Nail Mycosis
Businesswire.com Nov 02, 2024
Yapay zeka destekli sağlık girişimi Mindpeak, 15.3 milyon dolar yatırım aldı — Webrazzi
Yapay zeka destekli sağlık girişimi Mindpeak, 15.3 milyon dolar yatırım aldı
Webrazzi Oct 01, 2024
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology — Businesswire.com
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology
Businesswire.com Sep 30, 2024

Mindpeak Alternatives & Competitors

View All Alternatives
Mindpeak vs
Aiforia Technologies
Aiforia Technologies Finland

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.

IPO
81 employees
AI, Biotechnology
Compare Mindpeak vs Aiforia Technologies
Mindpeak vs
Ibex Medical Analytics
Ibex Medical Analytics United States

Pioneering AI-based cancer diagnostics in pathology

Series C
97 employees
AI, Analytics
Compare Mindpeak vs Ibex Medical Analytics
Mindpeak vs
SeraCare
SeraCare United States

LGC Clinical Diagnostics | Science for a Safer World

Private Equity
111 employees
Biotechnology, Health Care
View all alternatives

FAQ About Mindpeak

Our mission is to enable personalised cancer treatment through AI tissue diagnostics
Mindpeak was founded in 2018.
Mindpeak is headquartered in Hamburg, Germany.
Mindpeak operates in AI, Biotechnology, Health Care and Machine Learning. Its work centres on AI tissue diagnostics, personalised cancer treatment, medical image analysis and automation tools. Its customers include Biopharmaceutical companies, Diagnostic laboratories and Clinical researchers.
Mindpeak has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Mindpeak has approximately 53 employees.
Mindpeak has completed 4 funding rounds, raising a total of $19.67M. The latest funding stage is Series A.
Mindpeak offers: AI technology for biomarker discovery, Clinical trial support, Diagnostic imaging solutions, Automated macrodissection, Pathology frontier model development.
Top alternatives and competitors to Mindpeak include Aiforia Technologies, Ibex Medical Analytics, SeraCare, Onc.AI, Synthego. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mindpeak and Aiforia Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mindpeak, https://bouncewatch.com/company/mindpeak, updated 12 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes